GlassScriptPhysician profile
David W Mccomb
NPI 1396165676
$8,173.76
in general payments reported to CMS, 2019-2025
31 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $269 · 2021: $759 · 2022: $2,047 · 2023: $1,537 · 2024: $3,017 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,288 · Travel and Lodging: $1,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,287.71 |
| Travel and Lodging | $1,622.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,034.16 | 2021-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $719.07 | 2019-2024 | Repatha |
| Atricure, INC. | $660.78 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $578.74 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $556.19 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $511.14 | 2019-2024 | Jardiance |
| Pfizer INC. | $389.20 | 2021-2024 | |
| Boston Scientific Corporation | $351.52 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Astrazeneca Pharmaceuticals LP | $342.35 | 2019-2025 | Andexxa, Wainua, Brilinta |
| Inari Medical, INC. | $334.37 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $307.04 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $231.49 | 2019-2025 | Camzyos, Eliquis |
| Philips North America LLC | $221.71 | 2022-2024 | (Ck7) Extended Holter, (5044) Mcot, (Ck4) Mcot |
| United Therapeutics Corporation | $117.20 | 2020 | |
| Alnylam Pharmaceuticals INC. | $104.26 | 2025 | Amvuttra |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $87.99 | 2021 | |
| Bardy Diagnostics, INC. | $81.19 | 2022 | |
| Sanofi-Aventis U.S. LLC | $76.96 | 2019-2023 | |
| Medtronic, INC. | $71.34 | 2022 | |
| Merck Sharp & Dohme LLC | $71.03 | 2021-2023 | Verquvo |
| Baxter Healthcare | $63.56 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Chiesi USA, INC. | $47.55 | 2020-2022 | |
| Cardiovascular Systems INC. | $40.57 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $30.86 | 2024 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $27.73 | 2023 | Rotarexs 6 F X 135 Cm |
| Impulse Dynamics (USA) INC. | $26.83 | 2022 | |
| Lantheus Medical Imaging, INC. | $24.26 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.56 | 2022 | |
| Scpharmaceuticals INC. | $17.01 | 2023 | |
| Angiodynamics, INC. | $16.19 | 2023 | Soft-Vu |
| Actelion Pharmaceuticals US, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mccomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.